Carbon Dioxide
Medical Gases
Sold as CARBOGEN
- Drug class
- Medical Gases
- Availability
- Prescription only
- Routes
- Inhalation, Respiratory (Inhalation)
- Markets covered
- 3
- Products on record
- 16
- FDA reports (12 mo)
- 4
Overview
Plain-language summary, compiled from the cited regulatory records
Carbon Dioxide is classified as a medical gas [1]. This substance is not indicated for any specific approved uses according to the provided data [1].
In the market, Carbon Dioxide may be found under various brand names. The provided data includes 4 adverse event reports within the last 12 months [2]. The most frequent adverse events reported include abdominal distension, air embolism, drug ineffective for unapproved indication, fetal death, and injury associated with a device [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 3 | December 19, 2025 |
| CA Canada | Health Canada | 8 | March 22, 2025 |
| US United States | FDA | 5 | December 2, 2025 |
GBUnited Kingdom· MHRA
3 products
Uses
As a respiratory stimulant after apnoea or after chronic respiratory obstruction has been relieved. In clinical situations where carbon dioxide is needed as an anaesthetic supplement. Use in clinical and physiological investigations.
How to take
CACanada· Health Canada
8 products
8 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Brands in Canada (1)
USUnited States· FDA
5 products
5 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Most-reported reactions to the US regulator (12 mo to June 4, 2026): 4 reports total. [4]
- Abdominal Distension 1
- Air Embolism 1
- Drug Ineffective For Unapproved Indication 1
- Foetal Death 1
- Injury Associated With Device 1
- Maternal Exposure During Pregnancy 1
- Pneumoperitoneum 1
Sources & citations
- [1]MHRA (UK) · PL159290007 · revised July 18, 2025
- [2]Health Canada (DPD) · 00572861 · revised March 22, 2025
- [3]FDA DailyMed · 07ef001a-c648-56… · revised October 23, 2025 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.